Osteopore Ltd. ( (AU:OSX) ) has issued an announcement.
Osteopore Limited has entered into an exclusive two-year distribution agreement with Peakmed Co., Ltd, a Thailand-based medical device company, to distribute its craniofacial implants across 70 hospitals in Thailand. This strategic partnership aims to strengthen Osteopore’s market presence in Thailand, a key market due to the high volume of neurosurgical procedures, and aligns with the company’s strategy to expand its distribution channels in the growing Southeast Asian healthcare market.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company specializing in 3D-printed biomimetic and bioresorbable implants. The company is recognized as a global leader in producing these innovative implants, which are primarily used in craniofacial and neurosurgical applications.
YTD Price Performance: -57.50%
Average Trading Volume: 2,552,170
Technical Sentiment Signal: Buy
Current Market Cap: A$2.59M
See more data about OSX stock on TipRanks’ Stock Analysis page.